R. de Souza

Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002)

I. Mittra, A. Bhattacharjee, R. Badwe, 2020, medRxiv.

Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial

S. Dube, A. Suri, M. Joy, 2021, BMJ Open.

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)

Shashank Srivastava, A. Maurya, N. Sachdeva, 2020, medRxiv.

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

R. Guleria, S. Joshi, A. Trikha, 2020, medRxiv.

Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study

R. Dikshit, P. Chaturvedi, R. Badwe, 2021, BMJ Open.

Clinical characteristics and outcomes of patients with acute lung injury and ARDS.

R. Bhadade, M. Harde, R. de Souza, 2011, Journal of postgraduate medicine.

Maternal outcomes in critically ill obstetrics patients: A unique challenge

R. Bhadade, M. Harde, R. de Souza, 2012, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.